We are live on ! Find out more
RXIIW

RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021
RXIIW

Delisted

RXIIW was delisted on the 16th of November, 2018.

Back to rankings

5 hedge funds and large institutions have $1.31M invested in RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+5
Holders Change %
–
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$409K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$400K
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$383K
4
LTFS
Ladenburg Thalmann Financial Services
Florida
+$5.4K
5
UBS Group
UBS Group
Switzerland
+$1.01K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$454K +$409K +2,270,283 New
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$444K +$400K +2,222,222 New
Hudson Bay Capital Management
3
Hudson Bay Capital Management
Connecticut
$404K +$383K +2,127,661 New
LTFS
4
Ladenburg Thalmann Financial Services
Florida
$6K +$5.4K +30,000 New
UBS Group
5
UBS Group
Switzerland
$1K +$1.01K +5,600 New

RXIIW Hedge Fund Activity: Q4 2016 in Review

5 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 (RXIIW) for Q4 2016, worth a combined $1.31M.

Buyers outnumbered sellers: 5 funds opened new RXIIW positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $409K.

  • 5 institutional investors held RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 (RXIIW) as of Q4 2016, up from 0 in Q3 2016.
  • Funds reported $1.31M of RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 stock for Q4 2016.
  • 5 funds opened new RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 positions in Q4 2016 and 0 closed out, a net change of +5 holders.
  • The largest RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 buyer in Q4 2016 was Sabby Management, an estimated $409K added.

Based on aggregated 13F filings for Q4 2016.